The Bottom Line

Scalp psoriasis causes thick, silvery-white plaques and can be mistaken for dandruff — but it is a very different condition driven by immune system overactivity, not yeast. It affects 50 to 80% of people with psoriasis during their lifetime. The key distinction: the silver scales bleed when picked, and the condition does not respond to dandruff shampoos. With the right treatment — from prescription topical steroids up to advanced biologic injections — most people can achieve excellent control.

What Is Scalp Psoriasis?

Scalp psoriasis is a chronic inflammatory skin condition where the immune system causes skin cells to turn over much faster than normal. This rapid turnover piles up cells on the scalp surface, forming the characteristic red, raised patches covered with thick silvery-white scale. About 50 to 80% of people with psoriasis experience scalp involvement at some point, and for about 7% of patients, the scalp is the only area affected.

It is important to understand what scalp psoriasis is not: it is not a fungal infection, it is not contagious, and it is not caused by poor hygiene. It is an autoimmune condition with strong genetic roots — roughly 40% of people with psoriasis have a first-degree relative who also has it.

How Is It Different from Dandruff?

People often confuse scalp psoriasis with dandruff (seborrheic dermatitis), but there are clear differences:

  • Scale color and texture: Dandruff produces greasy, yellowish, powdery flakes. Scalp psoriasis produces thick, silvery-white, adherent scale.
  • The Auspitz sign: When psoriasis scale is gently removed, it often produces tiny pinpoint bleeding spots underneath. This does not happen with dandruff.
  • Borders: Psoriasis plaques have sharp, well-defined edges. Dandruff tends to be more diffuse without distinct borders.
  • Treatment response: Dandruff responds to antifungal shampoos. Scalp psoriasis does not — it requires prescription anti-inflammatory treatments.

Symptoms You May Notice

Scalp psoriasis can range from a few small patches near the hairline to plaques covering the entire scalp. Common symptoms include:

  • Red, raised patches with silvery-white, thick scale
  • Itching that ranges from mild to severe
  • Pain or tenderness, especially where scale is tightly adhered
  • Flakes visible on shoulders and clothing (heavier and more adherent than dandruff)
  • Plaques extending beyond the hairline onto the forehead, behind the ears, or down the back of the neck
  • Temporary hair shedding during severe flares (this reverses when the psoriasis is controlled)

What Triggers Flares?

Scalp psoriasis waxes and wanes. Common triggers for flares include:

  • Stress (emotional or physical)
  • Skin injury or trauma (Koebner phenomenon — psoriasis can appear at scratch sites)
  • Infections such as strep throat
  • Certain medications (beta-blockers, lithium, antimalarials)
  • Hormonal changes
  • Cold, dry weather

Treatment Options

Step 1: Topical Treatments (First Choice)

Most cases of scalp psoriasis begin with topical (applied directly to the scalp) therapies:

  • Potent topical corticosteroids: Clobetasol propionate 0.05% solution or foam, or betamethasone dipropionate 0.05% solution, applied twice daily. These are effective for 60 to 75% of people, typically within 2 to 4 weeks. Solutions penetrate through hair much better than creams. Use courses of 2 to 4 weeks to minimize the risk of skin thinning.
  • Scale-softening agents: Salicylic acid 3 to 6% applied overnight helps break down thick scale, allowing other treatments to penetrate more effectively.
  • Coal tar shampoos: 2 to 10% concentrations provide modest benefit (50–60% response) and serve well as adjuncts to prescription therapy.
  • Calcineurin inhibitors (steroid-free): Tacrolimus 0.1% or pimecrolimus 1%, with about 40 to 50% response, are a good long-term option for people who cannot use steroids continuously.

Step 2: Systemic Treatments (For Moderate to Severe Cases)

When topical treatments are not enough — especially if psoriasis involves a large portion of the scalp or has a major impact on quality of life — systemic therapy is the next step:

  • Methotrexate: 10 to 25 mg weekly (oral or injectable). Achieves 50 to 70% significant response within 12 weeks. Requires regular blood monitoring.
  • Acitretin: An oral retinoid (25 to 50 mg daily) that normalizes abnormal skin cell turnover. About 45% achieve PASI50 response. Strictly contraindicated in pregnancy.
  • Cyclosporine: Fast-acting but not suitable for long-term use due to kidney effects.

Step 3: Biologic Therapies (For Severe or Resistant Cases)

Biologic medications target the specific immune signals driving psoriasis and offer the highest response rates:

  • IL-17 inhibitors (secukinumab, ixekizumab): Among the fastest-acting options, often clearing scalp plaques within 2 to 4 weeks. Secukinumab achieves 80 to 90% significant response rates.
  • IL-23 inhibitors (risankizumab): Given as injections every 12 weeks after a loading dose; achieves 75 to 90% PASI90 response (90% improvement). Excellent durability between doses.
  • TNF-alpha inhibitors (etanercept, adalimumab): Well-established options with 60 to 85% significant response at 12 to 16 weeks.

Protecting Your Hair During Treatment

Scalp psoriasis is non-scarring — meaning it does not permanently damage hair follicles. However, severe inflammation and scratching can cause temporary shedding (telogen effluvium), which typically reverses within 3 to 6 months once the psoriasis is controlled. To minimize hair impact:

  • Avoid scratching, even when itching is intense
  • Use a soft-bristled brush or wide-toothed comb
  • Minimize heat styling (blow dryers, flat irons)
  • Use non-irritating, fragrance-free shampoos
  • Control the underlying psoriasis as promptly as possible

When to See a Dermatologist

  • Dandruff shampoos and over-the-counter products have not helped after 4 to 6 weeks
  • Scaling is thick, covering a large part of the scalp or extending beyond the hairline
  • Itching is severe or affecting sleep and daily activities
  • You notice significant hair shedding that does not recover
  • You have psoriasis elsewhere on your body that is not well-controlled
  • You want to discuss biologic therapy options

Frequently Asked Questions

Can scalp psoriasis spread to other parts of my body?

Yes — about 20 to 30% of people who start with scalp-only psoriasis develop additional involvement on the body within 5 years. However, many people maintain scalp-limited disease indefinitely. Having a plan in place with your dermatologist means you can respond quickly if the psoriasis spreads.

Is scalp psoriasis contagious?

No. Psoriasis is an immune-mediated genetic condition. You cannot give it to someone else through contact, shared combs, hats, or towels.

Will my hair grow back after I treat the psoriasis?

For most people, yes. Hair loss from scalp psoriasis is temporary (telogen effluvium), driven by active inflammation rather than follicle destruction. Once the psoriasis is controlled, hair typically regrows within 3 to 6 months. Permanent scarring alopecia from psoriasis alone is rare.

How quickly do the newer biologic treatments work?

IL-17 inhibitors like secukinumab and ixekizumab are among the fastest, with noticeable improvement often appearing within 2 weeks and peak results by 12 to 16 weeks. IL-23 inhibitors take slightly longer to reach maximum effect but offer very long intervals between injections (every 12 weeks). Your dermatologist can help you choose the right option based on your specific situation and other health factors.

References

  1. Kurd SK, Gelfand JM. The prevalence of previously diagnosed and undiagnosed psoriasis in the United States. J Am Acad Dermatol. 2009;60(2):218–224.
  2. Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker JNWN. Psoriasis. Lancet. 2021;397(10281):1301–1315.
  3. Langley RG, Elewski BE, Lebwohl M, et al. Secukinumab in plaque psoriasis — results of two phase 3 trials. N Engl J Med. 2014;371(4):326–338.
  4. Gordon KB, Strober B, Lebwohl M, et al. Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis. Lancet. 2018;392(10148):650–661.
  5. Menter A, Strober BE, Kaplan DH, et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis. J Am Acad Dermatol. 2019;80(4):1073–1113.
  6. Mrowietz U, Kragballe K, Reich K, et al. Definition of treatment goals for moderate to severe psoriasis. J Eur Acad Dermatol Venereol. 2011;25(Suppl 4):18–25.

Trusted Resources

Always consult a board-certified dermatologist for personal medical advice about your skin, hair, or scalp condition.